Absci Corporation (ABSI) Plans Phase 2 ABS-201 Endometriosis Trial for Mid-2027

Absci detailed a planned global, randomized Phase 2 trial of ABS-201 in endometriosis, targeting ~150 patients and a mid-2027 initiation, subject to regulatory clearance and protocol finalization.Material DetailsContext by AI AnalystThis is an early-to-mid stage pipeline update, outlining design an…